Shanghai Aladdin Biochemical Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XD0
CNY
12.96
-0.45 (-3.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
527.21
399.97
374.80
285.95
232.58
208.40
165.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
527.21
399.97
374.80
285.95
232.58
208.40
165.07
Raw Material Cost
224.58
185.86
174.52
119.40
98.04
66.98
51.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.44
7.27
5.17
0.81
0.66
0.66
0.77
Selling and Distribution Expenses
110.11
77.37
71.73
53.72
40.71
51.63
43.01
Other Expenses
4.80
3.77
2.96
1.98
1.30
1.36
1.05
Total Expenditure (Excl Depreciation)
391.14
308.21
281.01
193.73
152.43
132.89
105.62
Operating Profit (PBDIT) excl Other Income
136.1
91.8
93.80000000000001
92.2
80.19999999999999
75.5
59.400000000000006
Other Income
7.40
8.63
15.20
10.77
7.28
0.37
4.33
Operating Profit (PBDIT)
177.71
126.83
130.24
114.36
94.63
82.43
69.38
Interest
8.44
7.27
5.17
0.81
0.66
0.66
0.77
Exceptional Items
0.41
1.37
1.11
-0.09
0.73
0.14
0.12
Gross Profit (PBDT)
302.62
214.11
200.27
166.55
134.54
141.41
113.74
Depreciation
41.99
26.03
20.50
11.75
8.34
8.30
6.97
Profit Before Tax
127.70
94.89
105.67
101.71
86.37
73.61
61.76
Tax
11.91
9.08
12.90
12.35
11.94
9.92
8.34
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
98.76
85.83
92.77
89.36
74.43
63.69
53.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
98.76
85.83
92.77
89.36
74.43
63.69
53.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
16.96
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
115.72
85.83
92.77
89.36
74.43
63.69
53.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,066.07
1,036.40
974.80
858.32
816.70
346.18
322.72
Earnings per share (EPS)
0.29
0.26
0.27
0.27
0.22
0.19
0.16
Diluted Earnings per share
0.29
0.26
0.27
0.27
0.22
0.19
0.16
Operating Profit Margin (Excl OI)
24.34%
23.04%
25.22%
32.12%
33.97%
35.39%
35.19%
Gross Profit Margin
32.19%
30.23%
33.67%
39.68%
40.72%
39.31%
41.64%
PAT Margin
18.73%
21.46%
24.75%
31.25%
32.0%
30.56%
32.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 31.80% vs 6.72% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 34.85% vs -7.54% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 44.08% vs 2.78% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 15.07% vs 40.38% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shanghai Aladdin Biochemical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
527.21
0
527.21
Other Operating Income
0.00
0.00
0.00
Total Operating income
527.21
0
527.21
Raw Material Cost
224.58
0
224.58
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.44
0
8.44
Selling and Distribution Expenses
110.11
0
110.11
Other Expenses
4.80
0.00
4.80
Total Expenditure (Excl Depreciation)
391.14
0
391.14
Operating Profit (PBDIT) excl Other Income
136.06
0.00
136.06
Other Income
7.40
0
7.40
Operating Profit (PBDIT)
177.71
0
177.71
Interest
8.44
0
8.44
Exceptional Items
0.41
0
0.41
Gross Profit (PBDT)
302.62
0
302.62
Depreciation
41.99
0
41.99
Profit Before Tax
127.70
0
127.70
Tax
11.91
0
11.91
Provisions and contingencies
0
0
0.00
Profit After Tax
98.76
0
98.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
98.76
0
98.76
Share in Profit of Associates
0
0
0.00
Minority Interest
16.96
0
16.96
Other related items
0.00
0.00
0.00
Consolidated Net Profit
115.72
0
115.72
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,066.07
0
1,066.07
Earnings per share (EPS)
0.29
0
0.29
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
24.34%
0%
0.00
24.34%
Gross Profit Margin
32.19%
0%
0.00
32.19%
PAT Margin
18.73%
0%
0.00
18.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 52.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 31.80% vs 6.72% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 11.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 34.85% vs -7.54% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 44.08% vs 2.78% in Dec 2023

Annual - Interest
Interest 0.84 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 15.07% vs 40.38% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.34%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023